Biofrontera (BFRI) Receivables (2020 - 2026)
Biofrontera (BFRI) posted Receivables of $6.55 million for Q2 2026, up 65.5% from $3.96 million a year earlier.
Powered by 
Analysis
Biofrontera (BFRI) Receivables (2020 - 2026) Analysis & Trends
At the end of FY2025, Biofrontera's Receivables came in at $12.09 million, up 13.9% from FY2024.
- Annual Receivables shows a five-year compound annual growth rate of 29.7% (FY2020 to FY2025).
- In prior years, Biofrontera's Receivables was $10.62 million in FY2024 (+33.3%), $7.96 million in FY2023 (-22.3%), $10.25 million in FY2022 (-17.6%) and $12.43 million in FY2021 (+278.0%).
- Quarterly Receivables has run from a low of $2.06 million in Q3 2021 to a high of $16.47 million in Q1 2022 over five years.
- On a year-over-year basis, Receivables increased in five of the last seven quarters, with growth averaging 10.9%.
- The strongest year-over-year quarter for Receivables in the past five years was Q3 2022, with growth of 271.4%; the weakest was Q2 2024, with a decline of 64.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Biofrontera | 16.05 Mn | -5.74 Mn | 9.59 Mn | 6.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.55 Mn |
| Dec 31, 2025 | 12.09 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.96 Mn |
| Mar 31, 2025 | 4.23 Mn |
| Dec 31, 2024 | 10.62 Mn |
| Sep 30, 2024 | 4.87 Mn |
| Jun 30, 2024 | 3.50 Mn |
| Mar 31, 2024 | 3.69 Mn |
| Dec 31, 2023 | 7.96 Mn |
| Sep 30, 2023 | 6.51 Mn |
| Jun 30, 2023 | 9.89 Mn |
| Mar 31, 2023 | 7.87 Mn |
| Dec 31, 2022 | 10.25 Mn |
| Sep 30, 2022 | 7.66 Mn |
| Jun 30, 2022 | 7.60 Mn |
| Mar 31, 2022 | 16.47 Mn |
| Dec 31, 2021 | 3.88 Mn |
| Sep 30, 2021 | 2.06 Mn |
| Dec 31, 2020 | 3.29 Mn |
API Access
Biofrontera Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=BFRI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "BFRI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=BFRI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();